81 results on '"A Moschen"'
Search Results
2. Estimate of the rate of unreported COVID-19 cases during the first outbreak in Rio de Janeiro
3. Uterine microbiota plasticity during the menstrual cycle: Differences between healthy controls and patients with recurrent miscarriage or implantation failure
4. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19
5. A model for COVID-19 with isolation, quarantine and testing as control measures
6. Identification and expression analysis of NAC transcription factors potentially involved in leaf and petal senescence in Petunia hybrida
7. Placental morphometry in hypertensive disorders of pregnancy and its relationship with birth weight in a Latin American population
8. Identification and characterization of contrasting sunflower genotypes to early leaf senescence process combining molecular and physiological studies (Helianthus annuus L.)
9. Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease
10. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity
11. Critical review of the recovery rates of construction and demolition waste in the European Union – An analysis of influencing factors in selected EU countries.
12. FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry
13. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
14. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
15. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
16. Stable carbon and oxygen isotopes in sub-fossil Sphagnum: Assessment of their applicability for palaeoclimatology
17. Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice
18. Adiponectin and its receptors in patients with chronic hepatitis C
19. The RANKL/OPG system and bone mineral density in patients with chronic liver disease
20. Sa1765 SYMPTOMATIC REMISSION AND IUS IMPROVEMENTS IN A MULTINATIONAL REAL-WORLD COHORT OF UC PATIENTS TREATED WITH UPADACITINIB - FIRST RESULTS FROM THE IBD-DACH STUDY EUROPE.
21. Lactobacillus reuteri—an old acquaintance takes on a new task in colorectal tumor surveillance.
22. SAT-024 - Ethanol dampens IL-37 expression in liver tissue
23. Pathways of liver injury in alcoholic liver disease
24. Comments on “Anti-phase oscillation of Asian monsoons during the Younger Dryas period: Evidence from peat cellulose δ 13C of Hani, Northeast China” by B. Hong, Y.T. Hong, Q.H. Lin, Yasuyuki Shibata, Masao Uchida, Y.X. Zhu, X.T. Leng, Y. Wang and C.C. Cai [Palaeogeography, Palaeoclimatology, Palaeoecology 297 (2010) 214–222]
25. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation.
26. SAT-358 - Adipose type I interferon signalling protects against metabolic dysfunction
27. Circulating microRNA-122 is associated with incident metabolic syndrome and type-2 diabetes
28. THU-284 - Akkermansia Muciniphila Protects from Alcoholic Liver Disease
29. A response spectrum method for peak floor acceleration demands in earthquake excited structures.
30. Food, Immunity, and the Microbiome.
31. P006 The therapeutic potential of the pharmacological inhibition of PBEF/NAMPT/Visfatin in inflammatory bowel disease
32. The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism.
33. Mechanisms behind the link between obesity and gastrointestinal cancers.
34. P106 Active macrophage migration inhibitory factor (MIF) is a previously unrecognized isoform of MIF and a potential new biomarker for inflammatory bowel diseases
35. Non-alcoholic steatohepatitis: a microbiota-driven disease.
36. Visceral Adipose Tissue Attacks Beyond the Liver: Esophagogastric Junction as a New Target.
37. Obesity and the Microbiota.
38. Insulin resistance, inflammation, and non-alcoholic fatty liver disease
39. Interferon-alpha controls IL-17 expression in vitro and in vivo
40. Corrigendum to “IL-1 cytokine family members and NAFLD: Neglected in metabolic liver inflammation” [J Hepatol 2011;55:960–962]
41. Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction.
42. Antibacterial activity of the essential oils of Salvia officinalis L. and Salvia triloba L. cultivated in South Brazil
43. Transfer and early diagenesis of biogenic silica oxygen isotope signals during settling and sedimentation of diatoms in a temperate freshwater lake (Lake Holzmaar, Germany)
44. Supremum metric and relatively compact sets of fuzzy sets
45. High-temperature carbon reduction of silica: A novel approach for oxygen isotope analysis of biogenic opal
46. IL-1 cytokine family members and NAFLD: Neglected in metabolic liver inflammation
47. Efficient selection of up to three-component ground excitation sets for earthquake engineering applications.
48. P189 VISFATIN - A NOVEL MEMBER OF THE ADIPOCYTOKINE FAMILY IS ACTIVATED IN INFLAMMATORY BOWEL DISEASE
49. [113] PROGRESSIVE FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS - ASSOCIATION WITH ALTERED REGENERATION AND A DUCTULAR REACTION
50. 700 The novel adipokine visfatin is involved in the pathogenesis of NAFLD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.